Login
Home
Charts
Search
Watchlist
Products

Dishman Carbogen Amcis Ltd

DCAL·NSE
169.88-0.36%Tue, 22 Sept '26 15:57

Dishman Carbogen Amcis Ltd

DCAL
NSE
169.88
-0.36%
|Tue, 22 Sept '26 15:57
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
2,673Cr
Close
Close Price
170.50
Industry
Industry
Pharma - API & CRAMS
PE
Price To Earnings
165.53
PS
Price To Sales
0.92
Revenue
Revenue
2,901Cr
Rev Gr TTM
Revenue Growth TTM
0.20%
PAT Gr TTM
PAT Growth TTM
-84.49%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
587651655524789682716708653720851678
Growth YoY
Revenue Growth YoY%
-4.51.85.8-27.634.54.89.435.2-17.35.518.9-4.3
Expenses
ExpensesCr
526610592495642542564567504607688618
Operating Profit
Operating ProfitCr
6141632914714015314114911316360
OPM
OPM%
10.46.39.65.518.620.521.319.922.815.719.18.9
Other Income
Other IncomeCr
564-448-422871516
Interest Expense
Interest ExpenseCr
273331323749424342464337
Depreciation
DepreciationCr
758085717272798184848991
PBT
PBTCr
-36-66-49-784227283931-1046-51
Tax
TaxCr
5-7210922-1515-353247
PAT
PATCr
-41-60-70-78335432365-1322-58
Growth YoY
PAT Growth YoY%
-307.0-227.01.1-556.3180.9107.8161.6130.297.3-380.1-49.5-347.2
NPM
NPM%
-7.0-9.2-10.7-14.84.20.76.03.310.0-1.82.5-8.5
EPS
EPS
-2.6-3.8-4.5-5.02.10.32.81.54.2-0.81.4-3.7
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
587651655524789682716708653720851678
Growth YoY
Revenue Growth YoY%
-4.51.85.8-27.634.54.89.435.2-17.35.518.9-4.3
Expenses
ExpensesCr
526610592495642542564567504607688618
Operating Profit
Operating ProfitCr
6141632914714015314114911316360
OPM
OPM%
10.46.39.65.518.620.521.319.922.815.719.18.9
Other Income
Other IncomeCr
564-448-422871516
Interest Expense
Interest ExpenseCr
273331323749424342464337
Depreciation
DepreciationCr
758085717272798184848991
PBT
PBTCr
-36-66-49-784227283931-1046-51
Tax
TaxCr
5-7210922-1515-353247
PAT
PATCr
-41-60-70-78335432365-1322-58
Growth YoY
PAT Growth YoY%
-307.0-227.01.1-556.3180.9107.8161.6130.297.3-380.1-49.5-347.2
NPM
NPM%
-7.0-9.2-10.7-14.84.20.76.03.310.0-1.82.5-8.5
EPS
EPS
-2.6-3.8-4.5-5.02.10.32.81.54.2-0.81.4-3.7

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,2721,7141,6952,0592,0441,9122,1412,4132,6162,7122,9322,901
Growth
Revenue Growth%
13.2-1.121.5-0.7-6.412.012.78.43.78.10.2
Expenses
ExpensesCr
9821,2601,2491,5071,5461,6381,8092,0812,3292,2432,3662,416
Operating Profit
Operating ProfitCr
290453445552498274331332287469566485
OPM
OPM%
22.826.426.326.824.414.315.513.810.917.319.316.7
Other Income
Other IncomeCr
18254654441629-202245247
Interest Expense
Interest ExpenseCr
7949495762485786120159174169
Depreciation
DepreciationCr
84214211240283308308281311294339348
PBT
PBTCr
145216231309197-65-4-55-1221910515
Tax
TaxCr
4571769839100-22-2531167-1
PAT
PATCr
100145155210159-16518-30-15339716
Growth
PAT Growth%
76.76.336.1-24.6-204.2110.9-265.5-414.9102.12,907.7-84.5
NPM
NPM%
7.98.59.110.27.8-8.60.8-1.2-5.90.13.30.6
EPS
EPS
12.49.09.613.010.1-10.51.1-1.9-9.80.26.21.0
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,2721,7141,6952,0592,0441,9122,1412,4132,6162,7122,9322,901
Growth
Revenue Growth%
13.2-1.121.5-0.7-6.412.012.78.43.78.10.2
Expenses
ExpensesCr
9821,2601,2491,5071,5461,6381,8092,0812,3292,2432,3662,416
Operating Profit
Operating ProfitCr
290453445552498274331332287469566485
OPM
OPM%
22.826.426.326.824.414.315.513.810.917.319.316.7
Other Income
Other IncomeCr
18254654441629-202245247
Interest Expense
Interest ExpenseCr
7949495762485786120159174169
Depreciation
DepreciationCr
84214211240283308308281311294339348
PBT
PBTCr
145216231309197-65-4-55-1221910515
Tax
TaxCr
4571769839100-22-2531167-1
PAT
PATCr
100145155210159-16518-30-15339716
Growth
PAT Growth%
76.76.336.1-24.6-204.2110.9-265.5-414.9102.12,907.7-84.5
NPM
NPM%
7.98.59.110.27.8-8.60.8-1.2-5.90.13.30.6
EPS
EPS
12.49.09.613.010.1-10.51.1-1.9-9.80.26.21.0

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
160323231313131313131
Reserves
ReservesCr
1,0154,8145,0755,3475,6845,6675,5185,7785,5965,8006,646
Current Liabilities
Current LiabilitiesCr
6779941,1781,1981,5691,2901,4201,7982,5551,9252,317
Non Current Liabilities
Non Current LiabilitiesCr
5797868917519161,3771,6691,8451,3992,2432,929
Total Liabilities
Total LiabilitiesCr
2,2916,5937,1767,3288,2008,3668,6379,4549,5819,99911,923
Current Assets
Current AssetsCr
6731,3331,5461,5541,7791,7041,8391,9181,9282,2002,842
Non Current Assets
Non Current AssetsCr
1,6185,2605,6305,7756,4216,6626,7997,5357,6537,7999,081
Total Assets
Total AssetsCr
2,2916,5937,1767,3288,2008,3668,6379,4549,5819,99911,923
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
160323231313131313131
Reserves
ReservesCr
1,0154,8145,0755,3475,6845,6675,5185,7785,5965,8006,646
Current Liabilities
Current LiabilitiesCr
6779941,1781,1981,5691,2901,4201,7982,5551,9252,317
Non Current Liabilities
Non Current LiabilitiesCr
5797868917519161,3771,6691,8451,3992,2432,929
Total Liabilities
Total LiabilitiesCr
2,2916,5937,1767,3288,2008,3668,6379,4549,5819,99911,923
Current Assets
Current AssetsCr
6731,3331,5461,5541,7791,7041,8391,9181,9282,2002,842
Non Current Assets
Non Current AssetsCr
1,6185,2605,6305,7756,4216,6626,7997,5357,6537,7999,081
Total Assets
Total AssetsCr
2,2916,5937,1767,3288,2008,3668,6379,4549,5819,99911,923

Cash Flow

Consolidated
Standalone
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
137303226282585513355266379371491
Investing Cash Flow
Investing Cash FlowCr
-90-142-297-169-442-380-619-494-230-192-245
Financing Cash Flow
Financing Cash FlowCr
-50-13778-102-98-11130250-22-102201
Net Cash Flow
Net Cash FlowCr
-32371146122-1332212877447
Free Cash Flow
Free Cash FlowCr
3216422-26177147-101-35276156225
CFO To PAT
CFO To PAT%
136.9208.1146.5134.1369.1-310.51,970.3-892.5-247.311,459.3504.3
CFO To EBITDA
CFO To EBITDA%
47.366.850.951.1117.6186.9107.180.1132.479.286.9
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
137303226282585513355266379371491
Investing Cash Flow
Investing Cash FlowCr
-90-142-297-169-442-380-619-494-230-192-245
Financing Cash Flow
Financing Cash FlowCr
-50-13778-102-98-11130250-22-102201
Net Cash Flow
Net Cash FlowCr
-32371146122-1332212877447
Free Cash Flow
Free Cash FlowCr
3216422-26177147-101-35276156225
CFO To PAT
CFO To PAT%
136.9208.1146.5134.1369.1-310.51,970.3-892.5-247.311,459.3504.3
CFO To EBITDA
CFO To EBITDA%
47.366.850.951.1117.6186.9107.180.1132.479.286.9

Ratios

Consolidated
Standalone
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,1743,3808411,7092,9031,9553,6943,4122,0382,673
Price To Earnings
Price To Earnings
33.516.15.3161.01,036.220.9165.5
Price To Sales
Price To Sales
3.01.60.40.91.40.81.41.30.70.9
Price To Book
Price To Book
1.00.60.10.30.50.30.70.60.30.4
EV To EBITDA
EV To EBITDA
13.57.53.810.913.812.019.511.37.39.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
59.477.473.473.270.168.470.969.667.273.478.578.5
OPM
OPM%
22.826.426.326.824.414.315.513.810.917.319.316.7
NPM
NPM%
7.98.59.110.27.8-8.60.8-1.2-5.90.13.30.6
ROCE
ROCE%
12.24.74.65.83.7-0.20.70.40.02.22.92.9
ROE
ROE%
9.73.03.03.92.8-2.90.3-0.5-2.70.11.51.5
ROA
ROA%
4.42.22.12.91.9-2.00.2-0.3-1.60.00.80.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,1743,3808411,7092,9031,9553,6943,4122,0382,673
Price To Earnings
Price To Earnings
33.516.15.3161.01,036.220.9165.5
Price To Sales
Price To Sales
3.01.60.40.91.40.81.41.30.70.9
Price To Book
Price To Book
1.00.60.10.30.50.30.70.60.30.4
EV To EBITDA
EV To EBITDA
13.57.53.810.913.812.019.511.37.39.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
59.477.473.473.270.168.470.969.667.273.478.578.5
OPM
OPM%
22.826.426.326.824.414.315.513.810.917.319.316.7
NPM
NPM%
7.98.59.110.27.8-8.60.8-1.2-5.90.13.30.6
ROCE
ROCE%
12.24.74.65.83.7-0.20.70.40.02.22.92.9
ROE
ROE%
9.73.03.03.92.8-2.90.3-0.5-2.70.11.51.5
ROA
ROA%
4.42.22.12.91.9-2.00.2-0.3-1.60.00.80.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Dishman Carbogen Amcis Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/as-f2efd545cffc5694b5121ef1.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/i0eqwq0j70lhiipcj4w7xajl.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/u8uatty9a4xqr7aiwbvjv43p.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/08y2ni7v5n8kko4146z50ig2.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/ylpwu9c8w16ux0cpctof3w5d.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/fa7rcwug7eoh7a9hfwozjf88.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/v60y1fmdw87tevw9r33ctfy3.pdf
  • Q1 FY2025 Earnings Call Transcript (Jun 2024, PDF): https://www.stockscans.in/document/jnsggx87ucdyz6z7ffbp8mxc.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/kkm1ufk9f7o5x574kmtc0bw3.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/vgu0yyeew2xyp5qo89r2adxh.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/wot6vjkvxkk38sx135f6ko6t.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/455h6kr9uzo4s5mo4tna0l8c.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/8heh0czmxwini0qm0t5cxfia.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/ibudykn9qow8yjfuubh4lyio.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/zopmcor2dw6wqsukcmki0cqj.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/8bhhyxsnoo2bfxyskyr0akek.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/d9n9z2fz95f7kv6uwtj2n2rd.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/opyok6gnvnhvcx0ntwkg3fjv.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/gpmtjvg6mkyuccxzq320n8e7.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/facbj3mmilib9omgp4fw2kv4.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/wauy1s5j67b3yl6k24bc8nal.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/dvha50gfze4sy3zd05lzzv9i.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/mbu7jjg8otyxuz29tppailsp.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/k36d7hi8de4vcaxljt323irw.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/scqys5wpmv3b4hjlg6xv2mfo.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/yszw9fjsvhur2u4xys6l6dqu.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/uxmusoapmzft6t0otq8ezqwa.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/mcei0fm8ng6vudpqbrfzjsiv.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/0eqpk04l9e9s5i4qfu7mmtj9.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/geqnxcirf0t5d2z4q48jaq7s.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/cx7doo8cknhq4y9msqggn8o6.pdf

Concall Transcript Summaries — Dishman Carbogen Amcis Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3ADCAL/transcript-notes/202606/as-f2efd545cffc5694b5121ef1.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ADCAL/transcript-notes/202603/i0eqwq0j70lhiipcj4w7xajl.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3ADCAL/transcript-notes/202512/u8uatty9a4xqr7aiwbvjv43p.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ADCAL/transcript-notes/202509/08y2ni7v5n8kko4146z50ig2.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3ADCAL/transcript-notes/202503/ylpwu9c8w16ux0cpctof3w5d.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3ADCAL/transcript-notes/202412/fa7rcwug7eoh7a9hfwozjf88.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3ADCAL/transcript-notes/202409/v60y1fmdw87tevw9r33ctfy3.pdf
  • Q1 FY2025 Concall Transcript Summary (Jun 2024): https://www.stockscans.in/company/NSE%3ADCAL/transcript-notes/202406/jnsggx87ucdyz6z7ffbp8mxc.pdf